L3VLUP
ProSign in

RVTY · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

RVTYJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • RVTY
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterRVTYJNJ
Q3 202016 holders, $3.7bn30 holders, $26.2bn
Q4 202011 holders, $3.7bn32 holders, $26.6bn
Q1 20218 holders, $3.3bn31 holders, $25.3bn
Q2 202110 holders, $4.3bn37 holders, $25.6bn
Q3 202112 holders, $5.0bn40 holders, $24.1bn
Q4 20219 holders, $6.4bn33 holders, $25.2bn
Q1 20229 holders, $6.7bn35 holders, $28.2bn
Q2 202210 holders, $5.4bn33 holders, $26.9bn
Q3 20229 holders, $2.9bn36 holders, $25.4bn
Q4 202214 holders, $3.4bn35 holders, $27.6bn
Q1 202312 holders, $3.0bn42 holders, $24.5bn
Q2 202314 holders, $2.0bn38 holders, $25.0bn
Q3 202313 holders, $2.1bn37 holders, $18.9bn
Q4 20237 holders, $1.7bn31 holders, $19.0bn
Q1 202410 holders, $1.4bn32 holders, $19.7bn
Q2 20248 holders, $1.7bn35 holders, $20.4bn
Q3 20247 holders, $2.4bn28 holders, $22.3bn
Q4 20247 holders, $2.1bn37 holders, $20.4bn
Q1 20256 holders, $2.1bn32 holders, $20.5bn
Q2 20256 holders, $1.9bn31 holders, $18.4bn
Q3 20255 holders, $1.5bn32 holders, $23.7bn
Q4 202512 holders, $2.0bn29 holders, $27.8bn
Q1 20266 holders, $1.9bn34 holders, $35.6bn
Q2 20266 holders, $1.8bn33 holders, $39.1bn
RVTY

Perkinelmer Inc

Holders
6
Reported value
$2.1bn
Buyers
3
Sellers
5

Breadth -2 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
32
Reported value
$20.5bn
Buyers
16
Sellers
15

Breadth +1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2025

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only RVTY (1)

ExodusPoint Capital Management LP

Only JNJ (27)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, D. E. Shaw & Co., Dodge & Cox, Element Capital Management LLC, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Squarepoint Ops LLC, Two Sigma Advisers LP, Verition Fund Management LLC, Wellington Management Group LLP, and 2 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →